Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 4, 2008, Pages 551-558

  Blumer, J L ^a,b   Reed, M D ^a   Steinberg, F ^c   O'Riordan, M A ^a   Rosen, C L ^a   Springer, M A ^d   Christensen, M ^e   Glaze, D ^f  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Tennessee College of Medicine ^*

^d Louisiana State University Health Sciences Center   (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLPIDEM;

ACTIMETRY; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG SAFETY; EYE MOVEMENT; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MENTAL DISEASE; MULTICENTER STUDY; NEUROLOGIC DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SIDE EFFECT;

EID: 40949131028     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100380     Document Type: Article

References (45)

1. Owens, J.A., Palermo, T.M. & Rosen, C. Overview of current management of sleep disturbances in children: II-behavioral interventions. Curr. Ther. Res. 63 (suppl. B), B38-B52 (2002).
2. Owens, J.A., Spirito, A., McGuinn, M. & Nobile, C. Sleep habits and sleep disturbance in elementary school-aged children. J. Dev. Behav. Pediatr. 21, 27-36 (2000).
3. Mindell, J.A., Owens, J.A. & Carskadon, M.A. Developmental features of sleep. Child Adolesc. Psychiatr. Clin. N. Am. 8, 695-725 (1999).
4. Johnson, E.O., Chilcoat, H.D. & Breslau, N. Trouble sleeping and anxiety/depression in childhood. Psychiatr. Res. 94, 93-102 (2000).
5. Navelet, Y. Insomnia in the child and adolescent. Sleep 19 (suppl. 3), S23-S28 (1996).
6. Lippmann, S., Mazour, I. & Shahab, H. Insomnia: therapeutic approach. South Med. J. 94, 866-873 (2001).
7. Mellinger, G.D., Balter, M.B. & Uhlenhuth, E.H. Insomnia and its treatment: prevalence and correlates. Arch. Gen. Psychiatry 42, 25-32 (1985).
8. Radecki, S.E. & Brunton, S.A. Management of insomnia in office-based practice: national prevalence and therapeutic patterns. Arch. Fam. Med. 2, 1129-1134 (1993).
9. Pilcher, J.J. & Huffcutt, A.I. Effects of sleep deprivation on performance: a meta-analysis. Sleep 19, 318-326 (1996).
10. Glaze, D.G., Rosen, C.L. & Owens, J.A. Toward a practical definition of pediatric insomnia. Curr. Ther. Res. 63 (suppl. B), B4-B17 (2002).
11. Ali, D., Pitson, D.J. & Stradline, D.J. Snoring, sleep disturbance, and behaviour in 4-5 year olds. Arch. Dis. Child. 68, 360-366 (1993).
12. Adair, R.H. & Bauchne, H. Sleep problems in childhood. Curr. Probl. Pediatr. 23, 147-170 (1993).
13. Guilleminault, C., Winkle, R., Korobkin, R. & Simmons, B. Children and nocturnal snoring: evaluation of the effects of sleep related respiratory resistive and daytime functioning. Eur. J. Pediatr. 139, 165-171 (1982).
14. Hansen, D.E. & Vandenberg, B. Neurophysiological features and differential diagnosis of sleep apnea syndrome in children. J. Clin. Psychol. 26, 304-310 (1997).
15. Dahl, R.E. The impact of inadequate sleep on children's daytime cognitive function. Semin. Pediatr. Neurol. 3, 44-50 (1996).
16. Fallone, G., Owens, J. & Deane, J. Sleepiness in children and adolescents: clinical implications. Sleep Med. Rev. 6, 287-306 (2002).
17. Valent, F., Brusaferro, S. & Barbone, F. A case-crossover study of sleep and childhood injury. Pediatrics 107, E23 (2001).
18. Spiegel, K., Leprout, R. & Van Cauter, E. Impact of sleep debt on metabolic function. Lancet 354, 1435-1439 (1999).
19. Mindell, J.A. Sleep disorders in children. Health Psychol. 12, 151-162 (1993).
20. Mindell, J.A. & Durand, V.M. Treatment of childhood sleep disorders: generalization across disorders and effects on family members. J. Pediatr. Psychol. 18, 731-750 (1993).
21. Owens, J. et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J. Clin. Sleep Med. 1, 49-59 (2005).
22. Russo, R.M., Guraraj, V.J. & Alien, J.E. The effectiveness of diphenhydramine HCl in pediatric sleep disorders. J. Clin. Pharmacol. 16, 284-288 (1976).
23. Gordon, N. The therapeutics of melatonin: a paediatric perspective. Brain Dev. 22, 213-217 (2000).
24. Reed, M.D. & Findling, R. Overview of current management of sleep disturbances in children: I-pharmacotherapy. Curr. Ther. Res. 63 (suppl. B), B18-B37 (2002).
25. Adair, G.H. & Bauchner, H. Sleep problems in childhood. Curr. Probl. Pediatr. 23, 147-170 (1993).
26. Rosen, C., Owens, J.A., Sher, M.S. & Glaze, D. Pharmacotherapy for pediatric sleep disturbances: current patterns of use and target populations for controlled clinical trials. Curr. Ther. Res. 63 (suppl. B), B53-B66 (2002).
27. Prince, J.B., Wilens, T.E., Biederman, J., Spencer, T.J. & Wozniak, J.R. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J. Am. Acad. Child Adolesc. Psychiarty 35, 599-605 (1996).
28. Minde, K. The use of psychotropic medication in preschoolers: some recent developments. Can. J. Psychiatry 43, 571-575 (1998).
29. Trott, G.E., Badura, F., Wirth, S., Friese, H.J., Hollmann-Wehren, B. & Warnke, A. Self-assessm ent of prescribing behavior of psychotropic drugs for children and adolescents. Results of a survey of established physicians. Psychiatr. Prax. 22, 235-239 (1995).
30. Adams, S. Prescribing of psychotropic drugs to children and adolescents. BMJ 302, 217 (1991).
31. Kopferschmitt, J., Meyer, P., Jaeger, A., Mantz, J.M. & Roos, M. Sleep disorders and the use of psychotropic drugs in 6-year-old children. Rev. Epidemiol. Sante Publique. 20, 467-471 (1992).
32. Salva, P. & Costa, J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin. Pharmacokinet. 29, 142-153 (1995).
33. Thenot, J.P. et al. Pharmacokinetics and metabolism of zolpidem in various animal species and in humans. In Imidazopyridines in Sleep Disorders: A Novel Experimental and Therapeutic Approach (eds. Sauvanet J.P., Langer S.Z., Morselli P.L.) 139-153 (Raven Press, New York, 1988).
34. Albin, H., Vincon, G., Vincon, J., Hermann, P. & Thiercelin, J.F. Study of the pharmacokinetics of zolpidem in healthy volunteers after repeated administration: effects on antipyrine clearance. In Imidazopyridines in Sleep Disorders: A Novel Experimental and Therapeutic Approach (eds. Sauvanet J.P., Langer S.Z., Morselli P.L.) 369-370 (Raven Press, New York, 1988).
35. Desager, J.P., Hulhoven, R., Harvengt, C., Hermann, P., Guillet, P. & Thiercelin, J.F. Possible interaction between zolpidem, a new sleep inducer, and chlorpromazine, a phenothiazine neuroleptic. Psychopharmacology 96, 63-66 (1998).
36. Vandel, S., Vandel, B., Joanne, C., Trocherie, S., Bechtel, P. & Larribaud, J. Influence of ethnic origin on the clinical pharmacology of zolpidem. In Imidazopyridines in Sleep Disorders: A Novel Experimental and Therapeutic Approach (eds. Sauvanet J.P., Langer S.Z., Morselli P.L.) 390-391 (Raven Press, New York, 1988).
37. Colle, M. et al. Nocturnal profile of growth hormone secretion during sleep induced by zolpidem: a double-blind study in young adults and children. Horm. Res. 35, 30-34 (1991).
38. Patat, A. et al. EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology 114, 138-146 (1994).
39. Langtry, H.D. & Benfield, P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40, 291-313 (1990).
40. Merlotti, L., Roehrs, T., Koshorek, G., Zorick, F., Lamphere, J. & Roth, T. The dose effects of zolpidem on the sleep of healthy normals. J. Clin. Psychopharmacol. 9, 9-14 (1989).
41. Mindell, J.A. et al. Pharmacological Management of Insomnia in Children and Adolescents: (consensus statement) 1-2 November (National Sleep Foundation, Best Practice Management Inc., Baltimore, MD, 2004) (in press).
42. Glaze, D.G., Rosen, C.L. & Owens, J.A. Toward a practical definition of pediatric insomnia. Curr. Ther. Res. 63 (suppl. B), B4-B17 (2002).
43. Ring, P.R. & Bostick, J.M. Validation of a method for the determination of zolpidem in human plasma using LC with fluorescence detection. J. Pharm. Biomed. Anal. 22, 495-504 (2000).
44. Scharf, M.B., Mayleben, D.W., Kaffeman, M., Krall, R., Ochs, R. Dose response effects of zolpidem in normal geriatric subjects. J. Clin. Psychiatry 52, 77-83 (1991).
45. Kearns, G.L., Abdel-Rahman, S.M., Alander, S.W., Blowey, D.L., Leeder, J.S.S. & Kauffman, R.E. Developmental pharmacology - drug disposition, action and therapy in infants and children. N. Engl. J. Med. 349, 1157-1167 (2003).